Himalaya Nutravedics IPO
Bidding opens on 22 September 2026, in 6 days, and closes on 24 September 2026.
Subscription and grey market figures refresh on a 30-minute cycle. Last synced 16 September 2026. They are not a live tick-by-tick feed, so a bidding day can move between refreshes. Confirm current numbers on the exchange websites before you apply.
- Issue size
- ₹26.50 Cr
- Lot size
- 1,200 shares
- Minimum investment
- ₹1,27,200.00
- Face value
- ₹10.00
- Fresh issue
- ₹26.50 Cr
- Offer for sale
- ₹0.00 Cr
- Exchanges
- NSE and BSE
- Bidding dates
- 22 September 2026 to 24 September 2026
The dates that matter
An Indian IPO runs on a fixed calendar. Bidding stays open for three working days, the allotment is finalised the next working day, and the shares begin trading the day after that.
Anchor investor biddingNext
21 September 2026 in 5 days
One day before the public window, for institutional anchors.
Bidding opens
22 September 2026
Bidding closes
24 September 2026
Basis of allotment
25 September 2026
Refunds initiated
28 September 2026
Shares credited to Demat
28 September 2026
Listing on the exchange
29 September 2026
Issue dates
Grey market premium
No premium was quoted for this issue on any of the 1 day we hold a record for. A blank record is not a premium of zero, and it says nothing about demand either way.
About Himalaya Nutravedics
Himalaya Nutravedics India Ltd. makes Ayurvedic and nutraceutical products at a facility in Hyderabad, Telangana. The company runs two revenue lines. It sells its own branded formulations through healthcare practitioners, and it makes products for other Ayurvedic and nutraceutical companies under contract. Its range covers classical Ayurvedic formulations, proprietary products and nutraceutical supplements. Dosage forms include soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, medicated oils and protein powders. Products target digestive health, immunity, metabolic health, joint care, reproductive health, respiratory wellness and pain management. The company reaches 17 states and one union territory, with revenue concentrated in Telangana, Andhra Pradesh, Kerala, Gujarat and Uttar Pradesh. It employs 80 people as of April 30, 2026, and holds ISO 22000:2018, ISO 9001:2015 and WHO-GMP certifications.
Promoters
- Rohit Asawa
- Divya Asawa
- Chanda Asawa and Rama Raju Penmatsas
Financial highlights
The last three fiscal years as the offer document states them. Reading across a row shows whether the figure has grown, which is why the years run left to right.
| Metric (₹ crore) | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Assets | 6.09 | 10.82 | 24.42 |
| Total Income | 14.43 | 21.00 | 43.12 |
| Profit After Tax | 0.43 | 2.23 | 7.39 |
| EBITDA | 0.94 | 2.99 | 8.10 |
| NET Worth | 1.34 | 6.75 | 16.38 |
| Reserves and Surplus | 0.53 | 2.76 | 10.07 |
| Total Borrowing | 3.24 | 1.76 | 5.13 |
Figures are in ₹ crore and reproduced from the offer document, covering Mar 2024 to Mar 2026. A dash means the document does not state that figure for that period. A fiscal year ending March is labelled by its closing month, and where the document states a figure on a different basis the label here follows the document rather than normalising it.
Key ratios
Valuation and return ratios calculated from the issuer's financials. These are the figures the issue price is usually judged against, and the offer document carries the working behind each one.
| Ratio | Value | What it measures |
|---|---|---|
| Earnings per share | ₹11.72 | Profit after tax divided by the number of shares. |
| P/E at the cap price | 9.04x | Issue price divided by earnings per share. Lower is cheaper, but only against the same industry. |
| P/E after the issue | 12.63x | The same ratio recalculated on the larger post-issue share count. |
| Price to book | 3.97x | Issue price against net assets per share. |
| Net asset value per share | ₹26.70 | What the company owns, less what it owes, per share. |
| Return on equity | 63.87% | Profit earned on shareholders’ money. |
| Return on capital employed | 36.41% | Profit earned on all the capital in the business, including debt. |
| Return on net worth | 45.12% | The offer document’s own name for return on shareholders’ funds. |
| Debt to equity | 0.31x | Borrowings against shareholders’ funds. Higher means more leverage. |
| Profit margin | 17.16% | Profit after tax as a share of income. |
| Operating margin | 18.82% | Operating profit as a share of income, before interest, tax and depreciation. |
| Market capitalisation | ₹93.35 Cr | Value of the company at the issue price. |
Ratios are stated as published. A ratio that is absent here was not stated in the document, and is not the same as a ratio of zero.
What the money is for
Every issue states its objects in the offer document. These are reproduced from it, largest first, so you can see where most of the raise is going.
Funding Working Capital Requirements
₹13.75 Cr
Business Development and Digital Marketing Activities
₹7.50 Cr
General Corporate Purposes
Amount not stated
Peer comparison
The offer document compares the issuer against listed companies in the same business, on earnings, book value and return on net worth. Himalaya Nutravedics is the first row.
| Company | EPS (₹) | P/E | NAV per share (₹) | RoNW |
|---|---|---|---|---|
| Himalaya Nutravedics India Ltd.This issue | 12.05 | — | ₹26.70 | 45.12% |
| Jeena Sikho Lifecare Ltd. | 17.84 | 26.75 | ₹37.60 | 27.67% |
| Sandu Pharmaceuticals Ltd. | 1.83 | 20.62 | ₹45.21 | 2.53% |
Reproduced from the peer comparison in the offer document. A dash means the document does not state that figure for that company. It is absent, not zero. Ratios are reported on the basis named in the document, which is not always the same period for every company.
Questions people ask
One lot is 1,200 shares, and the block is calculated at the top of the price band, ₹106.00. That comes to ₹1,27,200.00 held in your bank account until the allotment is finalised. If you are not allotted, the block is released and the money never leaves your account.
Bidding runs from 22 September 2026 to 24 September 2026. Applications can be revised or withdrawn while bidding is open. Once it closes, the registrar finalises the basis of allotment the next working day and shares are credited the day after.
Retail applications run from 1 lot to 1 lots. The retail category caps an application at ₹2,00,000, so the upper limit is whichever comes first: the lot ceiling or the value ceiling.
Sources
- National Stock Exchange of India. "Upcoming and current public issues, with live bid quantities." The exchange publishes the bidding figures this page is built from, and is the authority on them. Accessed 15 September 2026.
- BSE. "Public issues — current and forthcoming." The second exchange carrying this issue, and the second source for its bidding data. Accessed 15 September 2026.
- Securities and Exchange Board of India. "Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018." The regulation that sets the issue process, the categories and the allotment rules. Accessed 15 September 2026.
- Himalaya Nutravedics issue particulars are compiled and published by DematOpen, refreshed every 30 minutes, and reviewed by the editorial team. The record was last updated 16 September 2026. The offer document and the registrar above are the primary sources for anything you intend to act on.